From the Food and Drug Administration.
Schwetz
B A
BA
Food and Drug Administration, Rockville, MD 20857, USA.
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D016108:Epidermolysis Bullosa Dystrophica / Q000601:surgery; D004941:Esophagitis / Q000188:drug therapy*; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006228:Hand Deformities, Congenital / Q000601:surgery; D006801:Humans; D009853:Omeprazole / Q000627:therapeutic use; D011310:Preservatives, Pharmaceutical; D016038:Skin Transplantation / Q000379:methods*; D017768:Skin, Artificial; D013849:Thimerosal; D014481:United States; D014486:United States Food and Drug Administration
D000897:Anti-Ulcer Agents; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D011310:Preservatives, Pharmaceutical; D013849:Thimerosal; D009853:Omeprazole